Drug Trial Radar · NCT01081145
Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD)
Last checked: Nov 20, 2026Latest source record: Jun 14, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
528
Actual
Start
May 11, 2010
Primary completion
Jun 3, 2013
Study completion Jun 3, 2013
Sponsor
- Lead sponsor
- ShireTakeda (TAK)
- Sponsor type
- Industry
- First posted
- Mar 5, 2010
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 6 years, up to 17 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study is to evaluate the long-term maintenance of efficacy of Extended-Release Guanfacine HCl in children and adolescents (6-17 years) with attention-deficit/hyperactivity disorder (ADHD) who respond to an initial open-label, short term treatment with SPD503.
Conditions
- Attention-deficit/Hyperactivity Disorder
Interventions
Extended-release Guanfacine HydrochlorideDrug
The test product will be provided as 1, 2, 3, and 4mg tablets. Subjects will be administered a once-daily dose between 1-7mg/day depending on age and weight.
PlaceboOther
Matching placebo will be provided as 1, 2, 3, and 4mg tablets. Subjects will be administered a once-daily dose of placebo between 1-7mg/day depending on age and weight.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With Treatment Failures During the Double-Blind Randomized-Withdrawal PhaseTime frame: 26 weeks
Locations
81 sites in 10 countries. Site status is shown where the registry gives one.
Harmonex Neuroscience Research
Dothan, Alabama
Clinical Study Centers, LLC
Little Rock, Arkansas
Psychiatric Centers at San Diego, Feighner Research
San Diego, California
Encompass Clinical Research - North Coast
Spring Valley, California
Elite Clinical Trials, Inc.
Wildomar, California
Florida Clinical Research Center, LLC
Bradenton, Florida
Sarkis Clinical Trials
Gainesville, Florida
Amedica Research Institute, Inc.
Hialeah, Florida
Clinical Neuroscience Solutions, Inc.
Jacksonville, Florida
Florida Clinical Research Center, LLC
Maitland, Florida
Clinical Neuroscience Solutions, Inc.
Orlando, Florida
AMR-Baber Research Inc.
Naperville, Illinois
Goldpoint Clinical Research, LLC
Indianapolis, Indiana
Louisiana Research Associates, Inc.
New Orleans, Louisiana
Delmarva Family Resources
Salisbury, Maryland
University of Nebraska Medical Center
Omaha, Nebraska
Center for Psychiatry and Behavioral Medicine, Inc.
Las Vegas, Nevada
Mount Sinai School of Medicine
New York, New York
Triangle Neuropsychiatry, PLLC
Durham, North Carolina
Ohio State University, Nisonger Center
Columbus, Ohio
IPS Research Company
Oklahoma City, Oklahoma
Oregon Center for Clinical Investigations, Inc. (OCCI, Inc.)
Salem, Oregon
CRI Worldwide, LLC
Philadelphia, Pennsylvania
FutureSearch Clinical Trials
Austin, Texas
ADHD Clinic of San Antonio
San Antonio, Texas
Alliance Research Group, LLC
Richmond, Virginia
Eastside Therapeutic Resource
Kirkland, Washington
Cliniques Universitaires Saint Luc
Brussels, Belgium
Huisartspraktijk Jaak Mortelmans
Ham, Belgium
Centre de référence Neuropédiatrique Multidisciplinaire
Namur, Belgium
Psypluriel
Uccle, Belgium
Ziekenhuis Inkendaal Koninklijke Instelling v.z.w.
Vlezenbeek, Belgium
Ziekenhuis Netwerk Antwerpen
Hoboken, Antwerpen, Belgium
Universitair Ziekenhuis Brussel
Jette, Brussels Capital, Belgium
Universitair Ziekenhuis Gent
Ghent, Oost-vlaanderen, Belgium
Children's and Women's Health Centre of British Columbia
Vancouver, British Columbia, Canada
JPM van Stralen Medicine Professional Corporation
Ottawa, Ontario, Canada
ADHD Clinic/The Kid's Clinic
Whitby, Ontario, Canada
Royal University Hospital
Saskatoon, Saskatchewan, Canada
Centre Hospitalier Universitaire Bocage-Hôpital d'enfants
Dijon, France
Showing 40 of 81 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.